Cargando…
Outcome of hairy cell leukemia patients treated with cladribine – a 10-year single-center experience in Pakistan
INTRODUCTION AND OBJECTIVE: Hairy cell leukemia is an uncommon, indolent B-cell lymphoproliferative disorder. Therapy with cladribine (2-chlorodeoxyadenosine) is able to induce complete remission (CR) in the majority of patients after a single course of treatment. We report the outcomes of patients...
Autores principales: | Zahid, Mohammad Faizan, Mehdi, Mohammad Qasim, Ali, Natasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517679/ https://www.ncbi.nlm.nih.gov/pubmed/31084763 http://dx.doi.org/10.1016/j.htct.2018.08.006 |
Ejemplares similares
-
Infections in patients with multiple myeloma treated with conventional chemotherapy: a single-center, 10-year experience in Pakistan
por: Zahid, Mohammad Faizan, et al.
Publicado: (2019) -
Remarkable Response of Hairy Cell Leukemia Variant to Single-Agent Cladribine
por: Otieno, Steve B, et al.
Publicado: (2022) -
Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients
por: Khorshid, Ola, et al.
Publicado: (2015) -
Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine
por: Bohn, Jan-Paul, et al.
Publicado: (2022) -
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study
por: Pagano, Livio, et al.
Publicado: (2022)